Investors: In Canada: Lawrence Chamberlain, NATIONAL Equicom, (416) 848-1457, [email protected]; In the United States: Thomas Hoffmann, The Trout Group LLC, (646) 378-2931, [email protected]; Media: Mike Beyer, Sam Brown Inc., (312) 961-2502, [email protected] CNW Group 2015
Cipher to present at TD Securities 2015 Technology & Healthcare Conference
Watch Cipher Pharmaceuticals' latest callCipher Pharmaceuticals (TSX:CPH) Q2 2026 Earnings Call · Replay · Aug 12Read the transcript of Cipher Pharmaceuticals (TSX:CPH) Q2 2026 Earnings CallView original source (CNW)Cipher Pharmaceuticals Inc. on 6ix
Story so far
Earlier from Cipher Pharmaceuticals
- Cipher Reports Third Quarter Results
- Notice of Cipher Pharmaceuticals Inc. Q3 2015 Conference Call
- Cipher announces settlement in patent litigation for Absorica®
- Cipher Reports Financial and Operational Results for Q2 2015
- Cipher Pharmaceuticals announces acceptance of 510(k) submission for Dermadexin(TM) by FDA
Later from Cipher Pharmaceuticals
- Cipher Pharmaceuticals to present at Piper Jaffray Healthcare Conference 2015
- Cipher Receives Health Canada Approval of (Pr)Beteflam(TM)
- Notice of Cipher Pharmaceuticals Inc. Q4 and Year-End 2015 Conference Call
- Cipher Pharmaceuticals Inc. announces Sitavig(TM) accepted for review by Health Canada
- Cipher Pharmaceuticals Inc. announces Canadian launch of Actikerall(TM)
Follow Cipher Pharmaceuticals into a list and get an email when it puts out news.
Follow Cipher Pharmaceuticals